Efficacy of oncolytic herpes virus G47. combined with immune checkpoint inhibitors in renal cell carcinoma models

被引:0
|
作者
Sasaki, Kenichi [1 ,2 ]
Takeshima, Yuta [1 ]
Iwai, Miwako [1 ]
Fukuhara, Hiroshi [3 ]
Kume, Haruki [2 ]
Todo, Tomoki [1 ]
机构
[1] IMSUT, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Fac Med, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3371
引用
收藏
页码:1571 / 1571
页数:1
相关论文
共 50 条
  • [31] Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma
    Ohnesorge, Paul V.
    Berchtold, Susanne
    Beil, Julia
    Haas, Simone A.
    Smirnow, Irina
    Schenk, Andrea
    French, Christopher A.
    Luong, Nhi M.
    Huang, Yeying
    Fehrenbacher, Birgit
    Schaller, Martin
    Lauer, Ulrich M.
    CANCERS, 2022, 14 (11)
  • [32] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2018, 78 (14) : 1443 - 1457
  • [33] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Ronan Flippot
    Bernard Escudier
    Laurence Albiges
    Drugs, 2018, 78 : 1443 - 1457
  • [34] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [35] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    CANCER JOURNAL, 2013, 19 (04): : 348 - 352
  • [36] Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Sakanoue, Ichiro
    Hamaji, Masatsugu
    Nakajima, Daisuke
    Date, Hiroshi
    THORACIC AND CARDIOVASCULAR SURGEON, 2025, 73 (01): : 86 - 89
  • [37] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [38] Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in renal cell carcinoma (TACITO trial).
    Porcari, Serena
    Ciccarese, Chiara
    Pinto, Federica
    Quaranta, Gianluca
    De Giorgi, Silvia
    Rondinella, Debora
    Settanni, Carlo Romano
    Cortesi, Enrico
    Roberto, Michela
    Primi, Francesca
    Buti, Sebastiano
    Fornarini, Giuseppe
    Masucci, Luca
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Tortora, Giampaolo
    Cammarota, Giovanni
    Segata, Nicola
    Iacovelli, Roberto
    Ianiro, Gianluca
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [39] Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128)
    Moinard-Butot, Fabien
    Thouvenin, Jonathan
    Bigot, Pierre
    Martinez-Chanza, Nieves
    Gaillard, Victor
    Cazzato, Roberto Luigi
    Boissier, Romain
    Margue, Gaelle
    Boudier, Philippe
    Maillet, Denis
    Gross-Goupil, Marine
    Bernhard, Jean-Christophe
    Barthelemy, Philippe
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
  • [40] Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC)
    Araujo, Daniel Vilarim
    Malone, Eoghan Ruadh
    Sacher, Adrian G.
    Fallah-Rad, Nazanin
    Sridhar, Srikala S.
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)